Outcomes of COVID-19 in Hematopoietic Stem-Cell Transplant Recipients: A Single Institution Observational Study

Intro: Hematopoietic stem-cell transplant (HSCT) recipients are considered to be at high risk for poor outcomes following COVID-19 infection given their co-morbidities and immunosuppression. Sharma et al published the CIBMTR observational report data that showed that recipients of allogeneic HSCT wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Dwabe, Sami, Savitala-Damerla, Lakshmi, Rodman, Jack, Ladha, Abdullah, Tam, Eric, Alachkar, Houda, Woan, Karrune, Chaudhary, Preet M., Yaghmour, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
731.Autologous Transplantation: Clinical and Epidemiological
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701613/
http://dx.doi.org/10.1182/blood-2021-149204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701613/
http://dx.doi.org/10.1182/blood-2021-149204

Ejemplares similares